Report Categories
View AllRecent Articles
View All
Is Liberty LBTYK stock showing technical strength Stuck 20260418
SDHY PGIM Short posts 151 EPS in Q1 incomefocused strategy supports gains as shares rise 025
GAMCO GGN Stock Strong Investment Pick Ticks Lower 20260415
Why Medical MPT Stock Matters Investors Pile In 20260420
Gladstone GOODO Stock Is It Trending Up Institutional Demand 20260420
Walmart Inc WMT
How Comstock Res CRK is solving the problems its peers cannot Eye on Rally 20260511
Corning Incorporated GLW Q1 2026 Earnings 070 EPS Surges Past 070 Estimates
Retiree Challenges Wealthy Savers Why Look Down on Those With Less A Response to the 22TimesIncome Letter
Voyager Technologies VOYG Q1 2026 Earnings Miss EPS 061 vs 058 Expected
Red Violet RDVT Q1 2026 Beat Revenue NA EPS Exceeds by Significant
Trumps Tariff Strategy Maintaining Policy Focus Despite Recent Court Setbacks
Australian Developer Scraps Trump Hotel Project Cites Toxic Brand
POET Technologies Expands Operational Footprint Shares Surge 13
LG Energy Solution Shares Surge 16 on Major US Battery Storage Deal
Chinas Industrial Profits Surge 247 in April Fastest Growth Since Late 2023
Ferraris First Electric Vehicle Faces Skepticism From Purists and Traditionalists
US Tech Stocks Sink as Chinas DeepSeek Triggers Broad AI Infrastructure Selloff
IREN Expands Brand Strategy Through Acquisition of Awaken
Shift4 Payments FOUR Q1 2026 Earnings Modest EPS Miss Amid Steady Operating Performance
JNJ Q1 2026 Earnings EPS Slightly Beats Estimates Amid Modest Stock Decline
FTAIM Q1 2026 Earnings Preferred Shares Steady as EPS Falls Short of Estimates
OVLY Q3 2023 Earnings Steady EPS of 089 Reported Flat Stock Reaction
EHTH Q1 2026 Earnings EPS Misses Estimates Sharply as Losses Deepen
Badger Meter BMI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter
Capital Bancorp Inc CBNK Holds Steady Near Key Resistance After Marginal Decline
Kyverna Therapeutics KYTX Faces Selling Pressure as Stock Nears Key Support at 824
Delta Air Lines Edges Higher Near Resistance DAL Tests Key Level After Modest Gain
Pliant Therapeutics PLRX Edges Higher as Stock Holds Above Key Support
Ernexa Therapeutics ERNA Slips 38 as Shares Test Key Support Near 1139